In individuals with AD, there is an upregulation of BIN1 expression in the brain, and the interaction between the SH3 domain of BIN1 and the proline-rich domain in tau contributes to the exacerbation of tau pathology (6). The gene discussed is MAPT; the disease is Alzheimer disease.